Partial agonist properties and toxicity of oral oxilorphan.
Alternative pharmacologic adjuncts are needed for the management of opiate abuse. Oxilorphan, a narcotic antagonist, was studied at 5 different dose levels (1, 2, 4, 6, and 8 mg) in 30 normal subjects to determine the relation of single oral doses and toxicity. The drug causes pupillary constriction and mild central nervous system side effects (nausea, dizziness) at all doses. Mean urine volume increased (P less than 0.05) during the 12 hours after 1 and 2 mg. Oxilorphan has partial agonist properties similar to dl-cyclazocine.
D000328:Adult; D006801:Humans; D008297:Male; D008875:Middle Aged; D009019:Morphinans / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity*; D009292:Narcotic Antagonists / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D011680:Pupil / Q000187:drug effects; D013997:Time Factors
D009019:Morphinans; D009292:Narcotic Antagonists; C008732:oxilorphan